Skip to main content
    N

    Nu Skin Enterprises Inc (NUS)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $3.80
    -0.13 (-3.31%)

    Market Cap: $191.31M

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Nu Skin Enterprises Inc (NUS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Nu Skin Enterprises (NUS) has a market cap of $191.31M and an enterprise value of $278.82M. Its trailing P/E of 5.2x is below its 10-year median of 12.4x. Its dividend yield is 6.32%.

    Total Valuation

    Enterprise value is 45.75% above the market cap, as debt exceeds cash.

    Market Cap$191.31M
    Enterprise Value$278.82M
    Latest price (Nov 17, 2026)$3.80

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 27, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Next Ex-Dividend DateNov 27, 2026
    Next Payment DateDec 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.17% in the quarter ended Sep 30, 2026 and shrank 1.04% a year over 2 years.

    Shares Outstanding48.68M
    Shares Change (YoY)-1.46%
    Shares Change (QoQ)+0.17%
    Share Count Growth (2Y CAGR)-1.04%

    Valuation Ratios

    Sales and book value multiples are 0.1x and 0.3x. Its year-end P/E ranged from 3.0x to 21.1x from 2016 to 2025.

    P/E Ratio5.2x
    Forward P/E4.6x
    P/S Ratio0.1x
    Forward P/S0.1x
    P/B Ratio0.3x
    P/TBV Ratio0.4x
    P/OCF Ratio12.6x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 10.9x EBITDA.

    EV / Sales0.2x
    EV / EBITDA10.9x

    Price Statistics

    The stock is down 59.98% over 52 weeks and trades 18.28% below its 50-day average.

    Beta (1Y)0.79
    52-Week Change-59.98%
    1-Month Change-23.54%
    3-Month Change-19.69%
    6-Month Change-31.81%
    5-Year Change-88.42%
    10-Year Change-92.46%
    Total Return (1Y)-57.45%
    Total Return (3Y CAGR)-39.11%
    Total Return (5Y CAGR)-37.35%
    Return vs SPY (1Y)-71.16%
    Max Drawdown (1Y)-66.49%
    Max Drawdown (3Y)-80.46%
    Sharpe Ratio (1Y)-1.97
    Correlation with SPY (1Y)0.24
    50-Day Average$4.65
    200-Day Average$5.92
    52-Week Range$3.84 to $11.33
    RSI (14 Days)32.8
    Average Volume (20 Days)566.26K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.04x current liabilities, and total debt is 0.46x shareholder equity.

    Current Ratio2.04x
    Quick Ratio1.22x
    Debt / Equity0.46x
    Debt / EBITDA10.09x
    Interest Coverage15.07x

    Returns and Efficiency

    Return on invested capital is -3.18% over the last 12 months, against a 5-year average of 5.38%.

    Return on Equity (ROE)-42.78%
    Return on Assets (ROA)-21.53%
    Return on Invested Capital (ROIC)-3.18%
    Return on Capital Employed (ROCE)-2.98%
    ROE (5Y Average)5.25%
    ROA (5Y Average)3.07%
    ROIC (5Y Average)5.38%
    Asset Turnover1.05x
    Inventory Turnover2.22x
    Receivables Turnover26.36x
    Cash Conversion Cycle151 days

    Scores

    NUS has an Altman Z-Score of 3.67, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score3.67
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.32B over the last 12 months is down 15.27% from the 12 months before.

    Revenue$1.32B
    Revenue Growth (YoY)-15.27%
    Gross Profit$896.94M
    Operating Income-$26.96M
    Pretax Income-$40.50M
    Net Income-$234.21M
    EBITDA$25.01M
    EBIT-$25.43M
    Reported EPS (TTM)$0.73

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 50.23% of the $1.09B in total assets.

    Cash and Equivalents$164.90M
    Total Debt$252.42M
    Net Debt$87.51M
    Net Debt Per Share$1.80
    Working Capital$244.23M
    Shareholder Equity$547.48M
    Book Value Per Share$11.25
    Tangible Book Value$506.35M
    Tangible Book Per Share$10.40
    Total Assets$1.09B
    Total Liabilities$540.60M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $41.46M of capital spending, operating cash flow left -$26.26M of free cash flow.

    Operating Cash Flow$15.21M
    Capital Expenditures$41.46M
    Free Cash Flow-$26.26M
    FCF Per Share-$0.54
    Depreciation and Amortization$50.45M
    Dividends Paid$18.12M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.04%, against a 5-year average of 2.36%.

    Gross Margin67.84%
    Operating Margin-2.04%
    Pretax Margin-3.06%
    Net Margin-17.72%
    EBITDA Margin1.89%
    EBIT Margin-1.92%
    FCF Margin-1.99%
    Gross Margin (5Y Average)70.64%
    Operating Margin (5Y Average)2.36%
    Net Margin (5Y Average)2.59%

    Growth

    Revenue fell 12.61% a year over 3 years, and EPS grew 3.41% a year.

    Revenue Growth (3Y CAGR)-12.61%
    Revenue Growth (5Y CAGR)-10.47%
    EPS Growth (3Y CAGR)+3.41%
    EPS Growth (5Y CAGR)-2.62%
    FCF Growth (3Y CAGR)-2.08%
    FCF Growth (5Y CAGR)-31.95%
    Operating Income Growth (3Y CAGR)-15.97%
    Book Value Per Share Growth (2Y CAGR)-1.45%
    Tangible Book Per Share Growth (2Y CAGR)+15.05%

    Revenue and profit by year

    Dividends and Yields

    NUS pays out 7.29% of earnings as dividends.

    Dividend Per Share (Annual)$0.24
    Dividend Yield6.32%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-46.19%
    Dividend Growth (5Y CAGR)-30.69%
    Payout Ratio7.29%
    Earnings Yield19.23%
    FCF Yield-14.20%
    Buyback Yield8.13%
    Shareholder Yield17.92%

    Full dividend history

    Peer Position

    Against 8 similar companies, NUS has the lowest P/E.

    P/E Ratio5.2x vs 17.6x median
    P/S Ratio0.1x vs 0.9x median
    ROIC-3.18% vs 2.15% median
    Revenue Growth (Trailing 4 Quarters, YoY)-15.27% vs -0.78% median
    Dividend Yield6.32% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -2.76% and EPS growth at -40.54% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-2.76%
    EPS Growth Forecast (2Y CAGR)-40.54%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NUS

    What is NUS's market cap?

    Nu Skin Enterprises has a market cap of $191.31M. Its enterprise value, which adds debt and subtracts cash, is $278.82M.

    What is NUS's P/E ratio?

    Nu Skin Enterprises has a trailing P/E ratio of 5.2x and a forward P/E of 4.6x.

    How many shares of NUS are outstanding?

    Nu Skin Enterprises has 48.68M shares outstanding. The count is down 1.46% from a year earlier.

    Does NUS pay a dividend?

    Yes. Nu Skin Enterprises pays $0.24 a share a year, a dividend yield of 6.32%.

    How much debt does NUS have?

    Nu Skin Enterprises has $252.42M of total debt and $164.90M of cash and equivalents, a net debt position of $87.51M.